AI-generated summary
The authors report an open-label pilot study of 15 people with generalized anxiety disorder who self-administered near-infrared light to the forehead daily for eight weeks, with 12 completing the trial. Anxiety and clinical severity scores decreased significantly, and sleep quality improved, with no serious adverse events reported. The authors describe the treatment as promising but call for larger, randomized, sham-controlled studies.
- Participants
- 15
- Who or what was studied
- People with generalized anxiety disorder (mean age 30 years, 67% women), 15 recruited and 12 completing an open-label 8-week trial
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The study was a small, open-label pilot with no control or sham group, so the results cannot establish that the light caused the improvement.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Energy density (fluence)
- 36 J/cm2
- Power density (irradiance)
- 30 mW/cm2
- Power
- 2.4 W
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Anxiety, Transcranial photobiomodulation, Pilot study, Effect size, Light-emitting diode, Irradiance. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.